Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection
Keywords: درمان ضد رتروویروسی; 5-OHdC; 5-hydroxydeoxycytidine; RT; reverse transcriptase; PBMCs; peripheral mononuclear cells; FMDV; foot-and-mouth disease virus; CC50; concentration needed to kill 50% of the cells; IC50; 50% inhibitory concentration; TCID50; tissue culture dose for 50